Stem Cell Treatment for Asthma/COPD/Pulmonary Fibrosis

We have seen success in treating all of these lung disorders with stem cell treatment. We are the first center to report successful treatment of an asthmatic patient with stem cells. A 68-year-old male with a longstanding history of asthma requested mesenchymal stem cell treatment for his persistent asthma symptoms. Cultured umbilical cord-derived mesenchymal stem cells were infused intravenously at a dose of 100 million cells over a period of 40 minutes. Post-treatment follow-up was performed after two and six months. The patient had no adverse events or complications related to treatment. In the two months posttreatment, his usage of a rescue inhaler decreased to 1 time per month, over 90% reduction. In addition, he had a 70% reduction in nebulizer usage. Improvement was sustained in the 6 months follow-up.

COPD and asthma can be treated with simple intravenous infusion of umbilical cord-derived stem cells.